Modern Medicine for Abortion
Use of Medicines Changing the Face of Abortion | January 27
2013
| Professor: Jaronda J. Miller, Sociology 100-174GA057-1132-001 | A Journal Article in Sociology |
Use of Medicines Changing the Face of Abortion
Denise Collins-Walker
Strayer University
Sociology 100 -174GA057-1132-001
Introduction to Sociology
January 27, 2013
ABSTRACT
The drug called mifepristone accompanied with the drug prostaglandin has been a blessing to many women around the world. Its use in the abortion process has saved the faces of many women who would like to remain discrete in this process; and in some countries that band abortion or have consider abortion to be inhumane; it is comforting to know that women still have a choice in deciding what to do with their bodies. Women today no longer have to be prodded and probed with instruments to terminate their pregnancies; they just have to swallow a combination of pills that is safe and has an accurate rate of about 98%.
Use of Medicines Changing the Face of Abortion
Winikoff, B., & Sheldon, W. (2012). Use of Medicines Changing the Face of Abortion.
International Perspectives On Sexual & Reproductive Health, 38(3), 164-166. The Use of Medicines Changing the Face of Abortion article has two types of reviews: existing research and new research. Its content deals with information about the medicine, why it was created, when it was created and how it is used in our society today. This article is primarily based on women’s issues with abortion around the world and how certain countries band the idea of abortion but yet women are still able to acquire the drugs and use it for its intended purpose. The type of research used in this article was, data that have already been collected by other existing sources, such as pharmaceutical and non-pharmaceutical clinicians.
In this article I learned that in 1980 the drug Misoprostol was originally developed for the use of gastrointestinal treatments and that it is
2013
| Professor: Jaronda J. Miller, Sociology 100-174GA057-1132-001 | A Journal Article in Sociology |
Use of Medicines Changing the Face of Abortion
Denise Collins-Walker
Strayer University
Sociology 100 -174GA057-1132-001
Introduction to Sociology
January 27, 2013
ABSTRACT
The drug called mifepristone accompanied with the drug prostaglandin has been a blessing to many women around the world. Its use in the abortion process has saved the faces of many women who would like to remain discrete in this process; and in some countries that band abortion or have consider abortion to be inhumane; it is comforting to know that women still have a choice in deciding what to do with their bodies. Women today no longer have to be prodded and probed with instruments to terminate their pregnancies; they just have to swallow a combination of pills that is safe and has an accurate rate of about 98%.
Use of Medicines Changing the Face of Abortion
Winikoff, B., & Sheldon, W. (2012). Use of Medicines Changing the Face of Abortion.
International Perspectives On Sexual & Reproductive Health, 38(3), 164-166. The Use of Medicines Changing the Face of Abortion article has two types of reviews: existing research and new research. Its content deals with information about the medicine, why it was created, when it was created and how it is used in our society today. This article is primarily based on women’s issues with abortion around the world and how certain countries band the idea of abortion but yet women are still able to acquire the drugs and use it for its intended purpose. The type of research used in this article was, data that have already been collected by other existing sources, such as pharmaceutical and non-pharmaceutical clinicians.
In this article I learned that in 1980 the drug Misoprostol was originally developed for the use of gastrointestinal treatments and that it is
References: Winikoff, B., & Sheldon, W. (2012). Use of Medicines Changing the Face of Abortion. International Perspectives On Sexual & Reproductive Health, 38(3), 164-166. 1. World Health Organization (WHO), Safe Abortion: Technical and Policy Guidance for Health Systems, second ed., Geneva: WHO, 2012. 2. TrussellJ and EUertson C, Estimating the efficacy of medical abortion. Contraception, 1999, 60(3): 119-135. 3. Fjerstad M et al. Rates of serious infection after changes in regimens for medical abortion. New England Journal of Medicine, 2009, 361(2):145-151. EBSCO databases website.